enidjakozh

Connexo quality newsletter: September 2025

September 1, 2025

Connexo quality newsletter: September 2025

Volume 32 reports on Connexo’s session at HLS Korea and previews the November PDA conference in Incheon. This issue also covers the TrackWise Digital Summer ’25 release, cleaning validation, and regulatory topics affecting quality teams.

HLS Korea session follow-up

Connexo at Honeywell Life Sciences World Tour Korea 2025

Connexo joined the Honeywell Life Sciences World Tour Korea on August 21, 2025, at the Enfold Hotel in Cheongju as a sponsor and speaker. The service and support session drew on the team’s experience implementing TrackWise-based quality management systems.

Topics included integrated document and training management, quality-data analysis using CoVA, computer system validation, and the use of TrackWise Digital and Help Desk support in daily operations.

PDA aseptic processing conference in November

PDA Aseptic Processing of Biopharmaceuticals Conference 2025

Connexo will sponsor the PDA Aseptic Processing of Biopharmaceuticals Conference on November 4–5, 2025, at the Sheraton Grand Incheon Hotel in South Korea. Early registration rates are available through September.

The first day will cover Annex 1 implementation, contamination control, emerging aseptic manufacturing technologies, and inspection findings, including discussion of USP <86>. The second day will focus on data integrity, supply and cold chains, packaging, and cell and gene therapy manufacturing.

View the conference agenda and registration information.

TrackWise Digital Summer ’25

Business meeting illustration

The TrackWise Digital Summer ’25 release is scheduled for deployment in September 2025. Clients should review the upgrade guidance provided by Connexo as part of their preparation for the rollout.

FDA concerns about compounded GLP-1 products

Illustration accompanying the compounded GLP-1 product report

The FDA has raised concerns about unapproved GLP-1 products, including compounded products made with semaglutide sodium or semaglutide acetate. These salt forms differ from the active ingredient in approved semaglutide medicines. The agency has said it lacks information establishing that they have the same chemical and pharmacological properties.

The FDA’s safety overview and compounding policy update explain the agency’s position. Further reading includes the Diabetes Care article and an EatingWell explainer.

Managing cleaning validation digitally

Cleaning validation lifecycle management

Cleaning validation records are often spread across protocols, spreadsheets, and reports. That makes it harder to follow retest dates, retrieve complete histories, and trace decisions during an inspection.

Connexo supports digital cleaning validation workflows that connect plans, results, and historical records. Scheduling alerts, electronic approvals, audit trails, and reports organized by equipment, product, or process help teams manage the work throughout the validation lifecycle.

Distribution guidance and safety monitoring

Illustration accompanying the regulatory update

Ireland’s HPRA published version 8 of its GDP guide in April 2025. It covers distribution controls, including temperature management, transportation, and documentation. Read the HPRA guide and the industry summary.

Annex 1 implementation remains a focus of the newsletter’s inspection coverage, particularly the connection between contamination control plans and day-to-day manufacturing practice.

In Korea, post-marketing safety reforms are moving the former re-examination system into an RMP-based framework. The linked MFDS policy material provides further background in Korean.

For inquiries, contact [email protected].